You are hereHome SectorsJordan
Tabuk Pharmaceuticals signs license and supply agreement with Selectchemie
Source: PRNewswire , Author: Posted by BI-ME staff
Posted: Fri October 6, 2017 11:56 am

JORDAN. -- /PRNewswire/ -- Tabuk Pharmaceutical Manufacturing Company ("Tabuk"), one of the leading pharmaceutical companies in the Middle East and North Africa (MENA) region, has entered into an agreement with Selectchemie, under which Selectchemie granted Tabuk a license to register, market and sell Caspofungin Injection (systemic antifungal agent) in Saudi Arabia, the Gulf Countries, North Africa, and the rest of Middle East.

Selectchemie is one of the leading European companies, headquartered in Zurich serving the pharmaceutical and human nutrition industries since 1969 as a premier supplier of high quality ingredients.

Dr. Rana Azzam, Senior VP of Business Development said "We are excited about this major partnership collaboration with Selectchemie. Caspofungin Injection is a hard to develop and lifesaving product. This partnership will provide an opportunity for both companies to leverage their combined strength."

Selectchemie side commented "Dr. Peter Kaufmann, CEO of Selectchemie, is proud to have gained Tabuk Pharmaceutical Manufacturing Company as a licensing and marketing partner for Caspofungin in the MENA Region. With this highest quality product, manufactured in Europe, Selectchemie looks forward to a long-term partnership with Tabuk to the benefit of both companies and end-users."

 

MIDDLE EAST BUSINESS COMMENT & ANALYSIS

date:Posted: April 23, 2018
UAE. Seventh annual PwC report shows how risk leaders around the world are effectively addressing challenges that accompany innovation.
date:Posted: April 22, 2018
UAE. As many as 492 hospitality projects worth US$39.4 billion are currently in progress - including tendering stage and under construction; The number of active hotel projects in the GCC reached 724, worth US$78 billion in March 2018.
date:Posted: April 20, 2018
INTERNATIONAL. Focus of the report is how we are nearing the end of the largest monetary policy experiment of all time in a backdrop of ascendant nationalism, staggering inequality and a widespread loss of hope among the younger generation.
dhgate